Nevro to Discuss Chronic Pain Solutions at Wells Fargo Healthcare Conference
Redwood City, California, 28 August 2024 â Nevro Corp. (NYSE: NVRO), a global medical device company providing comprehensive, life-changing solutions for chronic pain management, has announced that members of its management team will participate in a "fireside chat" at the Wells Fargo 2024 Healthcare Conference. The session, taking place on Friday, 6 September 2024, will commence at 8:45 a.m. EDT.
The fireside chat, which will include a question-and-answer session, will provide investors with an opportunity to gain insights into Nevro's latest developments and future plans. A live webcast of the session, along with a replay, will be available on the "Events and Presentations" page within the "Investors" section of Nevro's website at www.nevro.com.
Nevro regularly publishes information of potential interest to investors in the "Investor Relations" section of its website. The company encourages all stakeholders to visit the website frequently for updates and key information.
About Nevro
Headquartered in Redwood City, California, Nevro is a global medical device company dedicated to providing innovative solutions for chronic pain management. The company's mission is to help patients suffering from debilitating pain by offering evidence-based, non-pharmacologic treatments.
Nevro's proprietary 10 kHz Therapy⢠is a groundbreaking innovation that has positively impacted the lives of over 115,000 patients worldwide. The company's comprehensive HFX⢠spinal cord stimulation (SCS) platform, including the Senza® SCS system, offers treatment for chronic pain in the trunk and limbs, as well as painful diabetic neuropathy.
Nevro recently expanded its offerings with a minimally invasive treatment option for patients experiencing chronic sacroiliac joint (SI joint) pain. This addition provides Nevro with the most comprehensive portfolio of products in the SI joint fusion space, catering to various patient needs and physician preferences to improve patient outcomes and quality of life.
The Senza<sup>®</sup>, Senza II<sup>®</sup>, Senza Omnia<sup>®</sup>, and HFX iQ⢠are the only SCS systems to deliver Nevro's proprietary 10 kHz Therapyâ¢. To further support its patients and physicians, Nevro provides unique services, including HFX Coach⢠for patients throughout their pain management journey and HFX Cloud⢠for physicians to enhance patient and practice management.
Contact for Investors and Media:
Angie McCabe
Vice President, Investor Relations & Corporate Communications
angeline.mccabe@nevro.com
Trademarks and Patents:
SENZA, SENZA II, SENZA OMNIA, OMNIA, HF10, the HF10 logo, 10 kHz Therapy, HFX, the HFX logo, HFX iQ, the HFX iQ logo, HFX Algorithm, HFX CONNECT, the HFX Connect logo, HFX ACCESS, the HFX Access logo, HFX COACH, the HFX Coach logo, HFX CLOUD, the HFX Cloud logo, RELIEF MULTIPLIED, the X logo, NEVRO, and the NEVRO logo are trademarks or registered trademarks of Nevro Corp. Patents covering Senza HFX iQ and other Nevro products are listed at Nevro.com/patents.
Social Media:
Connect with Nevro on LinkedIn, X (formerly Twitter), Facebook, and Instagram.
